Literature DB >> 19781112

Trajectories of cognitive decline in Alzheimer's disease.

Patricia A Wilkosz1, Howard J Seltman, Bernie Devlin, Elise A Weamer, Oscar L Lopez, Steven T DeKosky, Robert A Sweet.   

Abstract

BACKGROUND: Late-onset Alzheimer disease (LOAD) is a clinically heterogeneous complex disease defined by progressively disabling cognitive impairment. Psychotic symptoms which affect approximately one-half of LOAD subjects have been associated with more rapid cognitive decline. However, the variety of cognitive trajectories in LOAD, and their correlates, have not been well defined. We therefore used latent class modeling to characterize trajectories of cognitive and behavioral decline in a cohort of AD subjects.
METHODS: 201 Caucasian subjects with possible or probable Alzheimer's disease (AD) were evaluated for cognitive and psychotic symptoms at regular intervals for up to 13.5 years. Cognitive symptoms were evaluated serially with the Mini-mental State Examination (MMSE), and psychotic symptoms were rated using the CERAD behavioral rating scale (CBRS). Analyses undertaken were latent class mixture models of quadratic trajectories including a random intercept with initial MMSE score, age, gender, education, and APOE 4 count modeled as concomitant variables. In a secondary analysis, psychosis status was also included.
RESULTS: AD subjects showed six trajectories with significantly different courses and rates of cognitive decline. The concomitant variables included in the best latent class trajectory model were initial MMSE and age. Greater burden of psychotic symptoms increased the probability of following a trajectory of more rapid cognitive decline in all age and initial MMSE groups. APOE 4 was not associated with any trajectory.
CONCLUSION: Trajectory modeling of longitudinal cognitive and behavioral data may provide enhanced resolution of phenotypic variation in AD.

Entities:  

Mesh:

Year:  2009        PMID: 19781112      PMCID: PMC2834298          DOI: 10.1017/S1041610209991001

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  29 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Psychological and physical adjustment to breast cancer over 4 years: identifying distinct trajectories of change.

Authors:  Vicki S Helgeson; Pamela Snyder; Howard Seltman
Journal:  Health Psychol       Date:  2004-01       Impact factor: 4.267

3.  Implications of latent trajectory models for the study of developmental psychopathology.

Authors:  Patrick J Curran; Michael T Willoughby
Journal:  Dev Psychopathol       Date:  2003

4.  Heterogeneity in Alzheimer's disease: progression rate segregated by distinct neuropsychological and cerebral metabolic profiles.

Authors:  U M Mann; E Mohr; M Gearing; T N Chase
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-10       Impact factor: 10.154

5.  Slower speed-of-processing of cognitive tasks is associated with presence of the apolipoprotein epsilon4 allele.

Authors:  Ruth O'Hara; Barbara Sommer; Nate Way; Helena C Kraemer; Joy Taylor; Greer Murphy
Journal:  J Psychiatr Res       Date:  2007-01-23       Impact factor: 4.791

6.  Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

Authors:  E H Corder; A M Saunders; W J Strittmatter; D E Schmechel; P C Gaskell; G W Small; A D Roses; J L Haines; M A Pericak-Vance
Journal:  Science       Date:  1993-08-13       Impact factor: 47.728

7.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

8.  Evaluation of dementia in the cardiovascular health cognition study.

Authors:  Oscar L Lopez; Lewis H Kuller; Annette Fitzpatrick; Diane Ives; James T Becker; Norman Beauchamp
Journal:  Neuroepidemiology       Date:  2003 Jan-Feb       Impact factor: 3.282

9.  Gender, cognitive decline, and risk of AD in older persons.

Authors:  L L Barnes; R S Wilson; J A Schneider; J L Bienias; D A Evans; D A Bennett
Journal:  Neurology       Date:  2003-06-10       Impact factor: 9.910

10.  The relationship of APOE polymorphism and cholesterol levels in normoglycemic and diabetic subjects in a biethnic population from the San Luis Valley, Colorado.

Authors:  M I Kamboh; C E Aston; R F Hamman
Journal:  Atherosclerosis       Date:  1995-01-20       Impact factor: 5.162

View more
  39 in total

1.  Effects of general medical health on Alzheimer's progression: the Cache County Dementia Progression Study.

Authors:  Jeannie-Marie S Leoutsakos; Dingfen Han; Michelle M Mielke; Sarah N Forrester; JoAnn T Tschanz; Chris D Corcoran; Robert C Green; Maria C Norton; Kathleen A Welsh-Bohmer; Constantine G Lyketsos
Journal:  Int Psychogeriatr       Date:  2012-06-12       Impact factor: 3.878

2.  Incident Psychosis in Subjects With Mild Cognitive Impairment or Alzheimer's Disease.

Authors:  Elise A Weamer; Mary Ann A DeMichele-Sweet; Yona K Cloonan; Oscar L Lopez; Robert A Sweet
Journal:  J Clin Psychiatry       Date:  2016-12       Impact factor: 4.384

3.  Race, APOEɛ4, and Long-Term Cognitive Trajectories in a Biracial Population Sample.

Authors:  Kumar B Rajan; Elizabeth A McAninch; Robert S Wilson; Jennifer Weuve; Lisa L Barnes; Denis A Evans
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

4.  Effects of Vitamin D Use on Outcomes of Psychotic Symptoms in Alzheimer Disease Patients.

Authors:  Lirong Wang; Jian Ying; Peihao Fan; Elise A Weamer; Mary Ann A DeMichele-Sweet; Oscar L Lopez; Julia K Kofler; Robert A Sweet
Journal:  Am J Geriatr Psychiatry       Date:  2019-03-27       Impact factor: 4.105

5.  Rapidly progressive Alzheimer's disease features distinct structures of amyloid-β.

Authors:  Mark L Cohen; Chae Kim; Tracy Haldiman; Mohamed ElHag; Prachi Mehndiratta; Termsarasab Pichet; Frances Lissemore; Michelle Shea; Yvonne Cohen; Wei Chen; Janis Blevins; Brian S Appleby; Krystyna Surewicz; Witold K Surewicz; Martha Sajatovic; Curtis Tatsuoka; Shulin Zhang; Ping Mayo; Mariusz Butkiewicz; Jonathan L Haines; Alan J Lerner; Jiri G Safar
Journal:  Brain       Date:  2015-02-15       Impact factor: 13.501

6.  Trajectory classes of depression in a randomized depression trial of heart failure patients: a reanalysis of the SADHART-CHF trial.

Authors:  Maragatha N Kuchibhatla; Gerda G Fillenbaum
Journal:  Am J Geriatr Pharmacother       Date:  2011-10-28

7.  Comparing measures of decline to dementia in amnestic MCI subjects in the National Alzheimer's Coordinating Center (NACC) Uniform Data Set.

Authors:  Sarah E Monsell; Danping Liu; Sandra Weintraub; Walter A Kukull
Journal:  Int Psychogeriatr       Date:  2012-04-16       Impact factor: 3.878

8.  TAR DNA-binding protein 43 pathology in Alzheimer's disease with psychosis.

Authors:  Anil Varma V Vatsavayi; Julia Kofler; Mary Ann A Demichele-Sweet; Patrick S Murray; Oscar L Lopez; Robert A Sweet
Journal:  Int Psychogeriatr       Date:  2014-03-04       Impact factor: 3.878

9.  Classification of mild cognitive impairment and Alzheimer disease using model-based MR and magnetization transfer imaging.

Authors:  R Wiest; Y Burren; M Hauf; G Schroth; J Pruessner; M Zbinden; K Cattapan-Ludewig; C Kiefer
Journal:  AJNR Am J Neuroradiol       Date:  2012-10-11       Impact factor: 3.825

10.  Plasma prion protein concentration and progression of Alzheimer disease.

Authors:  Christian Schmidt; Harry Becker; Christoph Peter; Katharina Lange; Tim Friede; Inga Zerr
Journal:  Prion       Date:  2014-02-18       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.